The Drug Enforcement Administration (DEA) has denied testimony from key witnesses ahead of scheduled hearings to discuss the potential classification of two psychedelic compounds, ...

The Drug Enforcement Administration has rejected witnesses and testimony from the group fighting to keep two psychedelic compounds out of Schedule I. The agency has a meeting scheduled in November to ...

In rapidly filed countermotions, advocates condemn the agency's attempt to "silence leading experts" in its pursuit of ...

Psychedelics are used by lot of people for counterculture and spiritual experiences. It also comes with the risk of misuse ...

New research by TIFR in collaboration with Cornell, Yale and Columbia discovers the brain pathway of how a psychedelic works ...

The drug, named DOI (2,5-dimethoxy-4-iodoamphetamine), was found to activate special brain cells, known as fast-spiking interneurons, in an area of the brain involved in controlling emotions and ...

Published in Neuron journal, the study led by Tata Institute of Fundamental Research also demonstrates the potential to ...

The findings show the psychedelic DOI (2,5-dimethoxy-4-iodoamphetamine) lessened anxiety in mice and rats while activating the ventral hippocampus and so-called fast-spiking interneurons there.

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Korea College of Pharmacy, CHA University, Pocheon, 487-010, Korea ...